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Abstract:
Networks of neurons known as central pattern generators (CPGs) generate rhythmic
patterns of output to drive behaviors like locomotion and respiration. These CPGs are relatively
fixed networks of neurons that produce consistent, stereotypical patterns in the absence of other
inputs. The heart contractions of the American lobster (Homarus americanus) are neurogenic
and controlled by a CPG known as the cardiac ganglion. Neuromodulators (e.g. amines, amino
acids, and neuropeptides) can enable flexibility in CPG motor output, thereby allowing
organisms to adjust to changes in their environment or sensory input. Neuromodulators have
been shown not only to exert effects on CPGs, but also to alter muscle contractions by acting on
the neuromuscular junction and the muscle itself.
A tissue-specific transcriptome gleaned from the cardiac ganglion and cardiac muscles of
the American lobster was used to predict sites and sources of a variety of crustacean
neuromodulators. Using a bioinformatics workflow, putative neuropeptides and receptors were
predicted utilizing the transcriptomes and then inferences were made about their potential
modulatory effects on the periphery of the cardiac neuromuscular system. If corresponding
receptors were predicted to be expressed in the cardiac muscle, then it was hypothesized that the
neuropeptide had peripheral effects. Receptors determined to be located at the cardiac muscle
included those for the following peptides and amines: C-type Allatostatin (AST-C), bursicon,
DH31, DH44, myosuppressin, octopamine (β receptor), octopamine-tyramine combo, and
serotonin.
One peptide that has been extensively studied and for which a cardiac muscle receptor
was identified is myosuppressin. Myosuppressin has been shown to have modulatory effects at
the cardiac neuromuscular system of the American lobster. In the whole heart preparation,
myosuppressin was found to enhance the contraction force. In the isolated cardiac ganglion,
myosuppressin increased burst duration and decreased cycle frequency and thus, the duty cycle
of the action potential bursts. Myosuppressin also has modulatory effects on the periphery of
cardiac neuromuscular system alone. It remains an open question of whether myosuppressin acts
on the cardiac muscle directly, if it is exerting its effects at the neuromuscular junction (NMJ), or
both.
To test this, I performed physiological experiments on the isolated NMJ. Myosuppressin
did not modulate the amplitude of the excitatory junction potentials. Since I did not observe any
effects at the NMJ, I next tested the effects of myosuppressin on the cardiac muscle. By isolating
the cardiac muscle from cardiac ganglion CPG and then stimulating muscle contractions using Lglutamate, I showed that myosuppressin increased contraction amplitude. Therefore, these data
suggest myosuppressin exerts its peripheral effects at the cardiac muscle and not the NMJ.
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Chapter 1: Introduction
1.1-Central pattern generators
Organisms’ ability to perform critical rhythmic behaviors that are necessary for survival,
like locomotion and respiration, are driven by neural networks that generate rhythmic motor
patterns. These networks of neurons are known as central pattern generators (CPGs). CPGs are
relatively fixed networks of neurons that produce consistent, stereotypical patterns in the absence
of other inputs.
The synaptic connections made between the neurons in a CPG can produce differing
rhythmic activity based on which specific neurons are active. One common motif is the firing of
pacemaker neurons that inhibit other network neurons and cause an oscillatory pattern (Marder et
al., 2001; Smith et. al. 1991). This oscillatory theory explains the contraction and relaxation of
muscles that produces rhythmic movement. The neurons in a motor CPG network innervate
muscle and drive contractions. The network of neurons, motor efferents, and the innervated
muscle comprise the CPG-effector system.
CPG-effector systems, which are present in in both vertebrates and invertebrates, produce
rhythmic behaviors that need to be flexible to allow organisms to adjust to changes in the
environment and sensory input (Dickinson, 2006). Neuromodulators like peptides and amines
acting on the CPG-effector system enable flexibility in the motor outputs. In some cases,
neuromodulators have been shown to activate the CPG circuit and alter muscle movements by
acting directly on the peripheral effector system, which is composed of both the neuromuscular
junction and the muscle (e.g. Bishop et al., 1984; Dickinson et al., 2015; Erxleben et al., 1995;
Jorge-Rivera and Marder, 1996).

1.2-The lobster’s heart as a CPG-effector system
The simplicity of invertebrate CPG-effector systems makes the American lobster
(Homarus americanus) an optimal experimental model. The lobster’s heart is part of an open
circulatory system in which the hemolymph, which acts as the blood of the lobster, flows in
through the ostia, dorsally and ventrally located on the heart, and is pumped out through the
anterior and posterior arteries (Figure 1). Unlike the human heart, which can contract
independent of any neural input (myogenic), the lobster cardiac neuromuscular system is
neurogenic and therefore muscle contractions are generated by neuronal input (Cooke, 2002).
This neural input comes from a cluster of neurons on the heart wall known as the cardiac
ganglion. The cardiac ganglion is one of the CPGs found in the lobster. It is a network of nine
neurons with four small, posterior pacemaker interneurons (Small Cells) and five large, anterior
motor neurons (Large Cells) arranged in a Y shape (Figure 1) (Cooke, 2002). Axons extend
beyond the ganglion, where they innervate and make synapses with the cardiac muscle (Yazawa
et al., 1999).
The pacemaker interneurons spontaneously generate bursts of action potentials that drive
the behavior of the motor neurons through both electrical and excitatory chemical synapses
(Cooke, 2002). In Hartline’s (1967) investigation of the neural activity at the cardiac ganglion, it
was discovered that the soma of the motor neurons is electrically unexcitable; action potentials
can only be initiated at the spike initiating zone located on the proximal axon. Driver potentials
in this region provide the underlying depolarization within the cells that can bring the membrane
potential over threshold at the spike initiating zone to cause a burst of sodium-based action
potentials. Driver potentials are long, sustained potentials mediated by calcium currents and three
different outward potassium currents: an early voltage-dependent A-current, a voltage dependent
delayed outward K-current, and a smaller, slow outward C current (Tazaki and Cooke, 1986).
2

Since the five motor neurons are electrically coupled, they fire these bursts synchronously. The
activity of the motor neurons acts on the cardiac muscle to cause a contraction in a unidirectional
manner.
The CPG-effector system is a closed feedback system (Figure 2). The increased calcium
concentration caused by enhanced muscle contraction results in the activation of a negative
feedback pathway. Increased calcium elicits the release of nitric oxide, which in turn decreases
the cycle frequency of contraction by acting on the cardiac ganglion (Mahadevan et al. 2004).
The muscle stretch also activates mechanosensitive receptors that provide feedback to the cardiac
ganglion and are thought to be a positive feedback pathway (Maynard, 1960). The dendrites, or
collateral processes, of the pacemaker and motor neurons are key players in sending signals to
the muscle fibers to activate this stretch feedback pathway (Hartline, 1979; Cooke, 2002;
Yazawa et al., 1999). The intrinsic feedback pathways are an important aspect of the CPGeffector system in stabilizing the heart’s activity.
Various neuropeptides and amines can modulate the CPG-effector system’s contractile
response and currents (Harris-Warrick et al, 1991). If neuromodulators are acting at any point in
the CPG-effector system, their modulation could alter the activity of subsequent regions.
However, the outputs are not always the same for each region within the CPG-effector system.
For example, Fort et al. (2007) discovered that the neuromodulator CCAP exerts counteracting
effects in the different regions of the cardiac neuromuscular system to ultimately stabilize the
CPG-effector system. These effects of CCAP suggest that other neuromodulators could have
similar effects.
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By observing the different ways that neuromodulators regulate each region of the CPGeffector system, we can gain more insight into the intrinsic and extrinsic mechanisms that drive
the changes in the rhythmic behaviors.

1.3- Physiology of the Neuromuscular Junction Physiology
The neuromuscular junction (NMJ) is the chemical synapse between the motor neuron
and the muscle fiber (Worden, 1998). The presynaptic axon terminal of the NMJ is identified by
a protein dense structure, which aids in the docking of transmitter loaded vesicles (Jahromi &
Atwood, 1974). There are varying numbers of active zones on the presynaptic membrane, with
some having no active zones at all (Levitan and Kaczmarek, 2015). The number of active zones
available at the presynaptic cleft determine how much transmitter is released and the magnitude
of the postsynaptic response. In crustaceans, the postsynaptic response to transmitter release is a
depolarization of the muscle membrane potential known as an excitatory junction potential
(EJP).
In vertebrates, the well-known transmitter that stimulates EJPs is acetylcholine; however,
in crustaceans, glutamate serves as the neurotransmitter for many NMJs to drive muscle
contractions. Glutamate rapidly increases sodium currents, causing a rapid depolarization in the
muscle followed by a steadier repolarization (Jan & Jan, 1976; Titlow & Robin, 2018). The EJP
amplitude is determined by a variety of factors, including the amount of transmitter released
from the presynaptic cell, the density of receptors on the postsynaptic membrane, the resistance
of the postsynaptic membrane, and the presence of recirculating modulators. The amplitude can
also vary based on the type of muscle response (e.g. spiking or graded muscle contractions)
(Titlow & Robin, 2018).
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When the neuron experiences repetitive stimuli, there is often an increase in transmitter
release, which is hypothesized to cause facilitation. Facilitation is thought to occur when
repeated action potentials result in calcium build-up at release sites, which does not have enough
time to return to lower, unstimulated levels before the next stimulus (Levitan and Kaczmarek,
2015). Thus, there is residual calcium in the presynaptic cell. The extra calcium then acts on a
neuronal calcium sensor protein (CaS), which enhances the activity of the calcium channels and
causes more calcium to enter the synaptic membrane with every action potential. Each
subsequent EJP at the NMJ is more enhanced than the last until the CaS reaches a point of
saturation or the stimulus ceases (Figure 3).

1.4-Muscle Physiology: Cardiac Striated Muscle
The cardiac muscle of the American lobster is striated muscle. Crustacean cardiac striated
muscles are non-propagating fibers, so neural input controls the force of contraction (Millar et al.
2005). Muscle contractions are graded.
Neuromodulators have been shown to alter muscle activity by modulating calcium
dynamics (Levitan and Kaczmarek, 2015). Contractions are controlled by levels of calcium
within the muscle fibers. When the muscle fibers are depolarized by CPG-generated action
potentials, calcium is released from sarcoplasmic reticulum. The sarcoplasmic reticulum
sequesters calcium within the muscle fiber, limiting the amount of free calcium within the cell.
Once released, free calcium binds to the contractile protein and elicits the contraction.
Neuromodulators acting on the cardiac neuromuscular system could influence any step of
this muscle contraction, some of the most obvious being the neurotransmitter release and calcium
dynamics in the muscle.
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1.5- Peptidergic Modulation
A well-studied group of neuromodulators is the neuropeptides. Peptides are chains of
amino acids that are covalently bound. Neuropeptides are encoded as chains of amino acids that
have signal sequences at their (N)-terminus and are known as preprohormones (Christie et al.
2010). Once synthesized, the preprohormones go through post translational processing, where
enzymes cleave the peptide at specific sites, making smaller chains of peptides. Many of these
peptides then undergo post-translational modifications, which are known to alter the peptide
structure, making the peptide biologically active and stabilizing it for cellular interactions and
neural output. Common structural changes in crustaceans can include disulfide bridges between
cysteines residues, tyrosine sulfation, and C- terminal amidation (Christie et al. 2010).
These neuropeptides can modulate the cardiac neuromuscular system at both an intrinsic
and extrinsic level (Katz, 1995). In H. americanus, intrinsic neuromodulators are synthesized and
released at the cardiac ganglion, then they act directly on the cardiac ganglion to control their
own modulation. Extrinsic modulators can be released: locally and/or hormonally. Hormonally
released extrinsic modulators are synthesized outside the cardiac neuromuscular system and
released into the hemolymph to travel through the circulatory system to reach the target cells.
The hormonally released neuromodulators can act on multiple target CPGs. Locally released
extrinsic modulators are synthesized and released in other regions of the nervous system (e.g.
thoracic ganglion) that have nerves going into the cardiac ganglion, where they are released at
the nerve terminals in the cardiac ganglion. Additionally, these modulators act on receptors in
peripheral regions and not at the cardiac ganglion.
By knowing the sites and sources of modulation, predictions can be made about whether
the neuromodulator modulates at the axon terminal, postsynaptic site, or the cardiac muscle.
Modulators acting at the axon terminal in the effector system have receptors located at the
6

presynaptic membrane of the NMJ and will be referred to as presynaptic modulators. Presynaptic
modulators can alter the calcium influx, the number of active zones, and the extent to which the
muscle depolarizes (Levitan and Kaczmarek, 2015). While modulators acting at the postsynaptic
site or muscle have receptors at the postsynaptic region of muscle and will be referred to as
postsynaptic modulators. Postsynaptic modulators can affect the receptor availability, the muscle
membrane resistance, and affinity of receptors. Neuromodulators could also regulate the muscle
function directly, altering the calcium dynamics, including modulation of the calcium
concentration that enters the muscle, the internal handling of calcium, or the affinity of troponin
for calcium. Increasing the amount of calcium bound through any of those pathways would result
in a larger contraction even with the same sized depolarization and/or amount of glutamate
released (Levitan and Kaczmarek, 2015).
Tissue-specific transcriptomes (e.g. cardiac ganglion and cardiac muscle) can be used to
make inferences about putative peptides’ site(s) of action. However, it becomes difficult to
determine a neuromodulator’s specific actions if receptors are located at both cardiac ganglion
and the cardiac muscle. If modulation is postsynaptic, it could be acting on either the cardiac
muscle or the NMJ. Tissue-specific transcriptomes cannot be made for the NMJ, due to mRNA
being located in the cell bodies and not the terminal; thus, bioinformatic cannot make predictions
about receptors located at this region. Bioinformatics also cannot determine the pathways at
which a neuromodulator alters the muscle contraction. Thus, to determine whether
neuromodulators act at the NMJ or directly affect the muscle contraction, physiological
experiments that isolate these regions are necessary. However, there are very few studies in
which these experiments have been performed. One of these few studies was Wilkens et al.

7

(2005), who showed that proctolin exerts effects on the periphery. They performed physiological
experiments that determined that proctolin exerted its effects on both the NMJ and the muscle.

1.6- Tissue-Specific Transcriptomics and Bioinformatics Utilized to Identify Putative
Neuropeptides and Receptors
To determine whether specific neuropeptides are likely to act as intrinsic or extrinsic
modulators in a CPG-effector system, tissue-specific transcriptomes have been analyzed.
Transcriptomics is a method in which the first step is to extract messenger RNA (mRNA) from
the tissue of interest. The mRNA holds the genetic information that leads to the formation of
proteins like neuropeptides and receptors. The Dickinson lab has collaborated with researchers at
the University of Hawaii at Manoa, who have used in silico transcriptomics to identify peptide
sequences at a large scale (Christie et al., 2015). With this method, the Dickinson lab and
collaborators were able to predict a variety of neuropeptides and receptors present within the
motor and pacemaker cells of the cardiac ganglion, cardiac muscle, eyestalk, brain, and other
tissues in the American lobster (Christie et al., 2015; Christie et al., 2017; Oliesky et al., 2020).
Using a bioinformatics workflow, putative neuropeptides or receptors can be predicted
from transcriptomes. Bioinformatics can also be used to make inferences about the structural
characteristics and location of the putative peptides and receptors. Through understanding the
potential localization of neuropeptides’ synthesis and release, predictions can be made about
their potential modulatory roles. Predicting the location of receptors can indicate the sites of
modulation for corresponding neuropeptides and whether they are intrinsic or extrinsic
modulators. Even though bioinformatics is a useful tool for preliminary research, it is necessary
to do physiological experiments to confirm these predictions.
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1.7- Myosuppressin
Using physiological methods, many neuromodulators have been shown to affect the
periphery; however, they have not been studied in detail. One such neuromodulator is the highly
conserved peptide, myosuppressin. Myosuppressin, characterized by its C terminal motifHVFLRFamide, is a well-studied neuropeptide in decapods and is a part of the FMRFamide-like
peptide family (Stevens et al., 2009). Oliesky et al. (2020) identified five putative myosuppressin
receptors in the brain-, eyestalk ganglia-, and cardiac ganglion-specific transcriptomes of H.
americanus. The distribution of these five myosuppressin receptors differed among the
pacemaker and motor neurons of the cardiac ganglion. Differing responses to myosuppressin
were also observed when studying the pacemaker and motor neurons separately.
Myosuppressin characteristically drives inhibitory responses in the muscle of various
arthropod species (Tanaka, 2016). However, in the cardiac neuromuscular system of the
American lobster, myosuppressin often results in muscular excitation. In the isolated whole
heart, for example, myosuppressin caused an increase the contraction amplitude (Figure 4). In an
isolated cardiac ganglion preparation, myosuppressin resulted in an increase in burst duration
and a decrease in cycle frequency of the action potential bursts (Stevens et al., 2009).
Stevens et al. (2009) also demonstrated that myosuppressin exerts modulatory effects at
the periphery. To isolate the periphery for experimentation, they eliminated all endogenous
cardiac ganglion activity, then stimulated the motor nerve to elicit transmitter release, causing a
single contraction for each stimulating burst. Myosuppressin was then superfused over the
lobster’s heart, resulting in an increase in the amplitude of contraction from baseline (Figure 5).
Although myosuppressin modulates the muscle contractions, it remains unclear whether the site
of action is the NMJ, the muscle, or both.
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The objective of these experiments was twofold. Firstly, I used bioinformatics to generate
a list of potential neuromodulators that may affect the cardiac neuromuscular system. I
determined whether they were predicted to be intrinsic or extrinsic modulators, and whether
receptors were in the cardiac ganglion or the cardiac muscle. Based on these results, I selected a
neuromodulator that was predicted to be present in both the cardiac ganglion and the cardiac
muscle and physiologically known to exert effects at the cardiac ganglion and the periphery. Yet
this selected neuromodulator’s effects at the periphery (NMJ and/or the muscle) remained
unknown. One such peptide that met these parameters was myosuppressin. Myosuppressin was
predicted to have receptors located on the cardiac ganglion and the cardiac muscle. Based on this
information and previous literature, it was predicted that myosuppressin exerted effects on both
the NMJ and the cardiac muscle. Physiological experiments were performed to determine the
site(s) of action at which myosuppressin exerts effects.
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Chapter 2: Methods
2.1- Animals
Lobsters (H. americanus) were purchased from seafood retailers in Brunswick, ME, and
were kept in a tank of recirculating seawater at 10-12 °C. They were fed scallops and shrimp
once a week.

2.2- Bioinformatics
2.2.1- Tissue Specific Transcriptomics
The H. americanus tissue-specific transcriptomes were assembled by Dr. Patsy
Dickinson’s lab, along with collaborator Dr. Andrew Christie’s lab. The mRNA was extracted
from brain, eyestalk, cardiac ganglion, and cardiac muscle tissue (Christie et al., 2015; Christie et
al., 2017). The mRNA reads were used to generate tissue-specific transcriptomes, which are
publicly available on the Hawaii database (http://clc01.pbrc.hawaii.edu/cgi-bin/blast/blast.html).
In order to predict the sites and sources of putative neuropeptides in the cardiac neuromuscular
system, the transcriptomes of the cardiac ganglion and the cardiac muscle were analyzed.

2.2.2- Bioinformatics Workflow
Using a well-vetted bioinformatics workflow, specific neuropeptides and receptors were
searched for using the transcriptome sequences. An established precursor sequence of the protein
of interest was used as the query sequence. Precursor protein sequences were either extracted
from the H. americanus transcriptome or a well-established Drosophila melanogaster
transcriptome (Veenstra, 2016; https://www.uniprot.org/; http://flybase.org/blast/). Using the
University of Hawaii Manoa BLAST software, the specific H. americanus tissue transcriptome
assembly was blasted using a tblastn against the query sequence. The program produced Trinity
numbers linked to aligning nucleotide sequences. The nucleotide sequence that corresponded to
11

the Trinity number was translated into an amino acid sequence using the program Expasy
(https://web.expasy.org/translate). Expasy produces six possible open reading frames (three
forward and three reverse). The longest sequence was selected because that is conceivably the
sequence that translates into the protein of interest. The selected open reading frame sequence
was aligned with its query sequence using the MAFFT alignment software
(https://mafft.cbrc.jp/alignment/software/). The amino acid sequences that were identical was
indicated by an asterisk (‘*’). The percent identity was calculated based on the similarity in
alignment. If there was a percent identity above 80 percent, the neuromodulator or receptor
would be predicted to be synthesized or present in the tissue. Using reciprocal blast programs,
the unknown proteins were blasted against known proteins using Flybase and NCBI Blast to
compare and make predictions about the identity of the unknown protein (Christie et al., 2015).
Using the program Flybase (http://flybase.org/blast/), the neuropeptide and receptor sequences
were compared to D. melanogaster annotated proteins. Using NCBI Protein Blast
(https://blast.ncbi.nlm.nih.gov/Blast.cgi), the proteins were blasted using a blastp and then
compared to non-redundant arthropods proteins, which allowed for a larger scale search.

2.2.3- Neuropeptides
Preprohormones, once cleaved by enzymes, become smaller peptides that undergo post
translational modifications that are known to cause changes in the peptide’s modulatory effects.
Enzyme cleavage sites were predicted based on the programs used (detailed below) and research
in Christie et al. (2017), which analyzed the transcriptomes of the eyestalk ganglia of the
American lobster. SignalP 5.0 (http://www.cbs.dtu.dk/services/SignalP/) and Neuropred
(http://stagbeetle.animal.uiuc.edu/cgi-bin/neuropred.py) software predicted the signal peptide
that promotes cleavage at that region. Using Expasy’s Sulfinator program
12

(https://web.expasy.org/sulfinator/), sites of tyrosine sulfation within the protein sequences were
predicted. “DiANNA” (http://clavius.bc.edu/~clotelab/DiANNA/) compares the putative peptide
isoforms to the current sequence and helped predict the disulfide bond formation between
cysteine residues. Other cleavage sites were manually predicted from previous research that
predicted common sites of cleavage like X-X-K-R↓, R-X-X-R↓, R-X-X-X-X-R↓, and RR↓ (‘↓’
indicates the point of cleavage) (Veenstra, 2000).

2.2.4- Receptors
Using the following programs, the characteristics and location of putative receptors were
predicted. The program WOLFpsort (https://wolfpsort.hgc.jp/) software was used to make
inferences about the location of the receptor within the cell (Wu et al., 2015). Using the program
Pfam (http://pfam.xfam.org/search/sequence), the specific structure of the receptor was
predicted. Many of the receptors were identified as 7 transmembrane receptors, indicating that
they are most likely G protein-coupled receptors (GPCRs). GPCRs usually signal a secondary
messenger pathway to exert their effect. Further investigations into the GPCRs were done with
the program TOPCONS (https://topcons.cbr.su.se/), which combines five topology methods
(OCTOPUS, Philius, PolyPhobius, SCAMPI, and SPOCTOPUS). The topology of the receptors
and the number of times the receptor passes through the cell membrane was estimated (Tsirigos
et al., 2015).

2.3 Physiological Experiments
2.3.1- Lobster Heart Dissection and Experimental Set Up
For physiological experimentation, the lobsters were anesthetized in ice for ~30 minutes.
The heart, which is located anterior to the tail and dorsally situated, was removed from the body
and detached from the carapace. The heart remained attached to the hypodermis and was placed
13

in a bath of physiological lobster saline (composition in mM: 479.12 NaCl, 12.74 KCl, 13.67
CaCl2, 20.00 MgSO4, 3.91 Na2SO4, 11.45 Trizma base, and 4.82 maleic acid; pH 7.45). Under
a dissecting microscope, the heart was opened to visualize the intact cardiac ganglion and the
muscle fibers.
A Rabbit peristaltic pump (Gilson, Middleton, WI) was used to superfuse saline over the
cardiac neuromuscular system at a rate of approximately 5ml/min. A Peltier temperature
regulator (CL-100 bipolar temperature controller and SC-20 solution heater/cooler; Warner
Instruments, Hampden, CT) was used to cool the saline. Due to the lobster’s thermal sensitivity,
it was critical that the saline temperature was maintained at 10-10.5oC to keep the cardiac
ganglion activity stable (Johnson et al., 1991; Tang et al., 2010; Oellermann et al., 2020).

2.3.2- Myosuppressin Preparation
Myosuppressin (pQDLDHVFLRFamide; MW = 1272.46 g/mol) was synthesized by
GenScript Corporation (Piscataway, NJ) and was stored as a stock solution at 10-3M and stored at
-20oC. Myosuppressin is relatively insoluble in water, so to make the stock solution, it was
dissolved in DMSO (15%) and deionized water. For experiments, stock solutions were diluted in
lobster saline to 10-7M.

2.3.3- The neuromuscular junction
To visualize the activity at the NMJ, the EJPs were recorded using a microelectrode filled
with squid cytoplasmic fill (20 mM NaCl, 15 mM Na2SO4, 10 mM Hepes, 400 mM potassium
gluconate, 10 mM MgCl2) (Hooper et al., 2015). The electrode was inserted into a single muscle
fiber. The intracellular activity was monitored by using an AxoClamp 2B amplifer (Axon
Instruments, Molecular Devices, LLC., San Jose, CA).
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However, before inserting the microelectrode, the cardiac ganglion was removed to
eliminate spontaneous EJPs (Figure 6A). The motor nerve ending was then stimulated using a
model 2100 Isolated Pulse Stimulator (A-M System, Sequim, WA) to elicit a contraction of the
muscle fibers in which it innervates. The intracellular electrode was then inserted into one of
those muscle fibers. The resting membrane potentials of the muscle fibers were between -30 and
-70 mV.
To evoke EJPs, the motor nerve ending was stimulated with three stimulating pulses,
resulting in three EJPs (Figure 6B). Each stimulation had a duration of 5 x 10-4 seconds and an
inter-pulse period of 0.4 seconds. Because each motor nerve required a different threshold
voltage to reliably generate an EJP, a range of voltages were required across preparations (2-7
V). Every 10 seconds, the three stimuli were delivered using a burst width of 1.1 seconds. Once
the preparation was stable for experimentation, myosuppressin was superfused over each
preparation for 20 minutes (Stevens et al., 2009). To ensure that the preparation’s activity
returned to baseline, a 40-minute saline wash was imposed.

2.3.4- Investigating the role of the cardiac muscle
To determine whether myosuppressin exerts an effect directly on the muscle, the cardiac
muscle contractions were measured in the absences of neuronal input using methods that were
adapted from Maguire (2019). The heart of the lobster was opened to visualize the cardiac
muscle and cardiac ganglion. A bundle of healthy cardiac muscle was located (either the left or
right longitudinal cardiac muscle), and hooks were glued perpendicular to each end of the bundle
using GluTure topical tissue adhesive (Zoetis Inc., Kalamazoo, MI) (Figure 7). For gluing, the
muscle fiber bundle was dried so that there was no physiological saline in the region that was to
be glued. Glue was allowed to dry to the muscle for 30 seconds before reapplying saline. A hook
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attached to a force transducer was perpendicularly placed gently on the center of the bundle. The
SI-H optical force transducer (WPI Inc., Sarasota, FL) measured the extent to which the muscle
contracted. The force transducer was calibrated to measure the force of contraction in grams.
Since the cardiac ganglion drives the contraction of the cardiac muscle, the cardiac
ganglion was completely removed from the preparation. Thus, the muscle fibers were isolated
from any stimulus and source of drive, while also completely bypassing the NMJ so that the
muscle activity could be independently measured.
Normally the NMJ releases the excitatory neurotransmitter glutamate onto the muscle to
cause a contraction (Delgado et al., 2000). Since the activity from the NMJ was eliminated, the
muscle was artificially stimulated using a Picospritzer II (General Valve Corporations, Fairfield,
NJ) to puff glutamate at 10-4M from an electrode (Glass, Standard, 1.0 MM x .5) cut with a tip of
about 15μm (Figure 7). The puff (pressure of 20psi and duration of 200ms) was administered on
a singular muscle fiber to induce contraction of that fiber (Aonuma et al., 1998).
Desensitization of the muscle from glutamate was observed when an alternative method
was initially used. Here, glutamate (10-3 M) was superfused over the muscle for 15-30 seconds
every three minutes (based on methods in Lingle (1980)). However, there was a clear decrease in
the muscle contraction with every superfusion, which was predicted to be attributed to the
muscle desensitization to glutamate (Titlow & Robin, 2018). This issue was resolved by
transitioning to the puffing method and using a lower concentration of glutamate.
Once the muscle showed a clear response to the glutamate, glutamate puffs were
repeatedly delivered every 100 seconds using a Grass S88 Stimulator (Grass Inst. Co., Quincey,
MA), to avoid the desensitization of the muscle fiber. When the muscle was stabilized,
myosuppressin (10-7 M) was superfused over the muscle for 20 minutes, to record its response on
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the cardiac muscle. After myosuppressin, the preparation underwent a 40-minute-long saline
wash to ensure that all the myosuppressin was eliminated from the preparation before continuing
experimentation. During the saline wash, glutamate was still repeatedly puffed. Only
preparations in which responses returned approximately to baseline were analyzed.
As a control, lobster saline was puffed onto the muscle to ensure that the mechanical
force of the puff application did not cause a muscle contraction.

2.3.5- Data Recording and Analysis
Analogue signals were digitalized at 10kHz using a Micro 1401 (CED, Milton,
Cambridge, UK) and recorded on Spike 2v7 (software; CED, Milton, Cambridge, UK).

Neuromuscular Junction
The amplitudes of the three stimulated EJPs (EJP 1, EJP 2, EJP 3) were measured by
using the “peak finder” function and the “minimum value” function in Spike 2. Since the EJPs
showed facilitation, I analyzed them as three separate groups: EJP 1, 2, and 3 in each condition
(e.g. saline control, myosuppressin, and wash).
For each heart preparation (N=6), amplitudes of the twelve sets of three stimulated EJPs
from 1-120 seconds prior to myosuppressin superfusion were averaged, as were the amplitudes
of the twelve EJP sets recorded 600-720 seconds after that start of myosuppressin superfusion.

Cardiac Muscle
The glutamate-evoked contraction amplitude was measured using a custom script that
found the maximum value of the force (in grams) after each glutamate puff. To analyze the
contraction change between saline and myosuppressin, the amplitudes of four stimulated
contractions, elicited 300-700 seconds before the onset of myosuppressin superfusion, were
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measured, as were contractions stimulated from 600-1000 seconds after the onset of
myosuppressin superfusion (N=5).

2.3.6- Neuromuscular Junction and Cardiac Muscle: Statistical Analysis
Prism v7.0 was used for statistical analysis and graphing (GraphPad Software, Inc., San
Diego, California). Using a paired t-test, the significance between saline and myosuppressin was
determined, with the significant value being less than 0.05.

18

Chapter 3: Results
3.1- Bioinformatics
Using the bioinformatics workflow, the sites and sources of modulation of a variety of
neuropeptides and their corresponding receptors were predicted.

3.1.1- Neuropeptides in the Cardiac Ganglion
Using the “cardiac ganglion combo” transcriptome, which includes both the pacemaker
interneurons and the motor neurons, twenty-five neuropeptides were analyzed to determine their
expression in the cardiac ganglion (Table 1). Of the neuropeptides searched for, sequences
encoding RNA were identified in the cardiac ganglion transcriptome for the following: C-type
allatostatin (AST-C), myosuppressin, proctolin, red pigment concentrating hormone (RPCH),
and tachykinin (CabTRP) (Table 2). These neuropeptides are predicted to be synthesized and
released from the neurons within the cardiac ganglion.

3.1.2- Receptors in the Cardiac Ganglion and Cardiac Muscle
Using the cardiac ganglion combo transcriptome, twenty-three receptors were analyzed to
determine their expression in the cardiac ganglion (Table 3). In the cardiac ganglion combo
transcriptome, of the receptors analyzed, sequences encoding RNA were present for those of the
following neuropeptides and amines: adipokinetic hormone-corazonin-like peptide (ACP), ASTC, buscicon, CCAP, diuretic hormone 31 (DH31), diuretic hormone 44 (DH44), myosuppressin,
octopamine (β receptor), proctolin, pyrokinin, and serotonin (Table 4). All eleven receptors were
identified as 7 transmembrane receptors and were predicted to be GPCRs.
Using the cardiac muscle transcriptome, twenty-two receptors were analyzed to
determine their expression in the cardiac muscle (Table 3). The receptors sequences encoding
RNA in the cardiac muscle transcriptome were present for those of the following neuropeptides
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and amines: AST-C, bursicon, DH31, DH44, myosuppressin, octopamine β, and serotonin (Table
5). All seven receptors were predicted to be 7 transmembrane GPCRs.
Since there can be multiple receptors for each neuropeptide, the specific receptor variants
are listed in Table 4 and 5. The percent identities to the query sequences for each present
neuropeptide and receptor identified in these transcriptomes are also indicated in Tables 2, 4, and
5.

3.1.3- Intrinsic and extrinsic modulation
From the bioinformatics workflow, AST-C and myosuppressin were predicted to be
intrinsic modulators. AST-C and myosuppressin were also predicted to be the only two (of those
analyzed) that might function as locally released extrinsic modulators. This suggests that many
of the other neuromodulators analyzed that have receptors located in the cardiac neuromuscular
system are released and synthesized in other systems of the lobster, such as the paracardial organ
or the eyestalk. However, since transcriptomes are often incomplete, it is possible that this
transcriptome did not include the sequences that are linked with the putative proteins of interest.

3.1.4- Myosuppressin
Five protein sequences that appear to be homologous to myosuppressin receptors (MSRI, II, III, IV, V) in other systems have been identified in the lobster nervous system (Oliesky et
al., 2020). For MSR IV, three variants were identified. MSR II-IV (all variants) were found in
the cardiac ganglion. I further investigated the MSRs and corroborated the results reported in
Oliesky et al. (2020), identifying MSR II-IV (all variants) in the cardiac ganglion. The MSRs
that were identified by Oliesky et al. (2020) had a partial or full alignment with the query
sequences with a 100 percent identity. In the present study, only MSR IV (variant 1 and 2) was
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identified in the cardiac muscle, with both variants being partial sequences. Both variants
showed 100 percent identity with the query sequences.

3.2- Physiological Experiments
3.2.1- Myosuppressin does not act at the neuromuscular junction
Since MSRs were predicted to be present in both cardiac ganglion and cardiac muscle
tissue, it was hypothesized that these receptors may be expressed at the presynaptic and/or
postsynaptic terminal of the NMJ, where myosuppressin binding could result in enhanced EJP
amplitude. Figure 8 shows that the mean EJP amplitudes recorded in control saline and during
the superfusion of 10-7M myosuppressin did not differ for any of the three consecutively
stimulated EJPs (paired t-test, p < 0.05; N=6). These data suggest that myosuppressin does not
act at the NMJ.

3.2.2- Myosuppressin Cardiac Muscle Results
Since MSRs were predicted to be present in cardiac muscle tissue, it was hypothesized
that these receptors may be expressed at the muscle, where myosuppressin binding could result
in altered muscle contraction. To test this, I applied myosuppressin at a concentration of 10-7M
over the muscle while recording from a single fiber. Figure 9 shows that myosuppressin induced
an increase in glutamate-evoked contractions of the cardiac muscle. Peak contraction amplitude
occurred around 600 seconds after myosuppressin was applied and then during the saline wash
the amplitude decreased steadily. There was an increase in the mean amplitude of the glutamateevoked contractions when myosuppressin (10-7M) was superfused compared to control saline
(paired t-test, p < 0.05; N=5) (Figure 10). These data suggest that myosuppressin is acting at the
cardiac muscle.
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Chapter 4: Discussion
A number of neuromodulators have been shown to exert effects on the lobster cardiac
neuromuscular system; of these, several have been found to exert effects on the NMJ and/or the
cardiac muscle (e.g. Wilkens et al., 2005; Dickinson et al., 2015). One of these neuromodulators
is proctolin, which is known to modulate both the NMJ and the muscle (Wilkens et al., 2005).
Surprisingly, in my investigation of the cardiac muscle transcriptome, RNA encoding the
proctolin receptor was not found. However, that does not mean proctolin cannot act at the
muscle, as shown in Wilkens et al. (2005). Instead, it suggests that the cardiac muscle
transcriptome is incomplete. Since both myosuppressin and proctolin enhance contractions of the
intact heart, it may be possible that they use analogous mechanisms, in which case we might
expect them to exert effects at the periphery similarly. Interestingly, while myosuppressin did not
appear to modulate at the NMJ, I show that myosuppressin exerts effects directly on the cardiac
muscle. However, since there was a small sample size for analyzing the effects of myosuppressin
on both the NMJ and the cardiac muscle, these are preliminary results that can be further studied
using the same methodology.

4.1- Proctolin modulates the NMJ via altered membrane resistance and regulates the cardiac
muscle via L-type Ca2+ channels
Proctolin was found to cause an increase in the muscle membrane resistance at the
postsynaptic membrane, leading to an increase in EJP amplitude (Erxleben et al., 1995).
Conversely, my results which indicate that myosuppressin does not modulate the EJPs and, thus,
it seems unlikely to alter muscle resistance. Muscle membrane resistance was not measured in
this experiment. However, there was no obvious, observable change in membrane potential when
myosuppressin was applied (data not shown).
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To examine the effect of myosuppressin on calcium dynamics in the muscle, one can
measure changes in the Ca2+ concentration, using a fluorescent calcium indicator similar to
methods used in Wilkens et al. (2005). They show that the extent to which the cardiac muscle
contracted with proctolin was proportional to an increase in Ca2+. These data suggest that
proctolin affects the Ca2+ dynamics; however, the mechanism of action remains unclear.
This method would inform us about whether Ca2+ does play a role in modulation.
Wilkens et al. (2005) shows that the cardiac muscle had an enhanced muscle force during
proctolin application, results that are similar to the effect myosuppressin had on the cardiac
muscle. There are at least two processes that could underlie this phenomenon: modulation of Ttype Voltage gated Ca2+ channels or Ca2+ release from L-type Ca2+ channels in the sarcoplasmic
reticulum (SR). Proctolin does not affect the T-type Ca2+ channels. In the presence of T-type
Ca2+ blockers (nifedipine, verapamil, and Cd2+), proctolin still enhanced contraction, showing the
T-type Ca2+ receptors are not sufficient to drive the proctolin-induced increase in contraction.
However, with ryanodine, which is a L-type Ca2+ blocker, they found that contraction was
suppressed even with application of proctolin, suggesting that proctolin needs the sequestered
Ca2+ from the SR to cause enhanced contraction. Moreover, when they applied proctolin and
caffeine, which elicits Ca2+ release from the SR, there was a faster and stronger proctolininduced contraction in comparison to when caffeine was not present. This suggests that the Ca2+
release from L-type Ca2+ channels mediate the effect of proctolin on the muscle. Performing a
similar experiment using myosuppressin would aid in determining whether Ca2+ dynamics are
altered by activation of myosuppressin receptors in the cardiac muscle of the lobster.
Myosuppressin receptor IV (variants 1 and 2) was predicted to be located at the cardiac
muscle. Pfam and Topcons predicted these variants to be GPCRs based on their characteristic 7
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transmembrane structure. Many GPCRs activate secondary messenger pathways that can alter
calcium dynamics within the muscle, which would allow them to modulate the contraction. In
vertebrate cardiac muscle, the cAMP pathway usually elicits muscle contraction (Kuo & Ehrlich,
2015). Myosuppressin GPCRs are not well understood. However, in Drosophila, proctolin
GPCRs were found to modulate cardiac muscle contraction through activation of both cAMP and
IP3 pathways (Hiripi et al., 1979; Lange, 1988; Hinton & Osborne, 1996; Baines et al., 1990).
Both pathways activate the release of Ca2+ from the SR, which supports evidence that proctolin
mediates sequestered Ca2+ release as observed by Wilkens et al. (2005).
As mentioned, myosuppressin could be eliciting a variety of different mechanisms,
including activation of secondary messengers, altered calcium dynamics in the muscle, or both.
Another possibility is that myosuppressin could indirectly mediate ion channels through
activating the G-protein. However, this is unlikely, since there was no obvious change in the
membrane potential with myosuppressin (data not shown). Membrane potential was not
measured in this experiment, so future research could be done looking at this parameter for more
insight on the G-protein pathway. Myosuppressin could also affect a combination of these
mechanisms listed and that combination could result in the response seen at the cardiac muscle.

4.2- Myosuppressin is a FMRFamide-like peptide
Myosuppressin is part of the larger FMRFamide-like peptide (FLP) family.
Myosuppressin has been shown to have inhibitory effects, however, in the American lobster,
myosuppressin drives responses with an excitatory component in the cardiac neuromuscular
system of the American lobster (Tanaka, 2016; Stevens et al. 2009). Activated FRMFamide
GPCRs have been studied in the cardiac muscle of the squid (Loligo forbesii) and were found to
alter calcium in the cardiac muscle (Chrachri et al., 2000). In the squid, there are two types of
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cardiac muscle—type I, which is a smooth surfaced membrane while type II has a more
invaginated surfaced membrane. FLPs act on the L-type Ca2+ channels, but not on T-type Ca2+
channels in both muscle types. Interestingly, the two muscle types responded to FLP differently.
In type I cardiac muscle, FLP suppressed the L-type Ca2+ channels through a GPCR pathway
and, in type II muscles, FLP caused a calcium current influx, which was not triggered by a
GPRC (Chrachri et al., 2000). Since myosuppressin shares similar structural elements to FLPs
and is known to cause increased contractile responses in the cardiac muscle, the altered Ca2+
dynamics caused by myosuppressin may be similar to that seen from FLP acting on the type II
muscle. However, the myosuppressin receptor has also been predicted to be a GPCR, thus
resembling the pathway that resulted in the suppression of contraction seen in type I muscle.
Information about the membrane surface structure of the cardiac muscle in the American lobster
is not known, so it is unclear whether the muscle would resemble type I or II squid cardiac
muscle more closely. Moreover, FLPs have differing effects on the varying cardiac muscle due
to the complexity of downstream receptor pathways. Experiments are needed to confirm
myosuppressin receptors as GCPRs, through observing expression of common secondary
messengers like cAMP and IP3. Furthermore, studying the structure of the cardiac muscle in the
American lobster would contribute to the understanding of its commonalities with squid cardiac
muscle.

4.3- Differing Effects of Neuromodulators Based on Receptor Variants and Distribution
It is possible that the multiple myosuppressin receptors could exert different effects
through varying G-protein or other signaling pathways. For instance, in the stomatogastric
nervous system of Cancer borealis, serotonin released from the same presynaptic neuron drove
different responses in three postsynaptic neurons: LG, MCN1 axon terminals, and DG (Delong et
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al., 2009; Kiehn et al., 1992; Powell et al. 2020). It is hypothesized that the serotoninergicmediated responses were distinct based on the types of 5-HT receptors expressed by these
neurons. It has also been hypothesized that the distribution of those different receptors in the
tissue lead to unique responses in different cells. Oliesky et al. (2020) found that myosuppressin,
when acting on the pacemaker interneurons and the motor neurons separately, produced differing
responses. They hypothesized that this could be attributed to the varying distribution of the
myosuppressin receptors I-V, alongside the hypothesis that the receptors also exert different
effects.

4.4- Myosuppressin may alter the neuromuscular transform
Because the cardiac neuromuscular system of the lobster is subject to stretch-induced
positive-feedback and the nitric oxide negative-feedback, understanding more about how
myosuppressin modulates contractions would provide further insight into how the heartbeat is
regulated in these animals. For instance, we know that modulation of the cardiac ganglion output
alters the heart contraction amplitude through the non-linear neuromuscular transform (NMT)
(Williams, 2013). The NMT is the activity that results from specific motor neuronal patterns
transforming into muscle contractions. Mapping the NMT activity allows inferences to be made
about whether there is facilitation or defacilitation of muscle contractions, providing information
that can help us understand how modulators exert their effects. William et al. (2013) mapped the
NMT activity by observing how the contraction amplitude depended on duty cycle and burst
frequency. Although the NMT is non-linear, the cardiac muscle showed stronger contractions
with decreased cycle frequency and duty cycle. Myosuppressin is known to increase the burst
duration while decreasing the duty cycle and cycle frequency of action potential bursts in the
isolated cardiac ganglion (Stevens et al., 2009). Based on Williams et al. (2013), the burst
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activity of myosuppressin would increase contraction amplitude. This trend has been specifically
attributed to facilitation of contractions due to the decreased duty cycle for contraction
(Williams, 2013; Stevens et al., 2009). Through understanding the relationship between the
neural circuits and the motor outputs, there can be a greater understanding of how these complex
pattern generators are modulated.

4.5- Other Neuromodulators’ Effects on the Periphery of the Cardiac Neuromuscular System
AST-C is one of the neuromodulators that has been analyzed in an isolated periphery
(Wiwatpanit et al., 2012). There are four receptors that have been predicted to be in the cardiac
neuromuscular system based on homologous sequences to AST-C receptors in other systems. Of
those four, receptor 1 and 2 have been shown to be functional, while receptor 3 and 4 have been
found to be non-functional (Walsh, 2017; J. Joe Hull, personal communication). In my
investigation of the cardiac muscle, I predicted that receptor 1 and 2 were expressed in cardiac
muscle (Table 5). Interestingly, Wiwatpanit et al. (2012) found that AST-C did not alter activity
at the NMJ or cardiac muscle. These results reveal that receptors predicted to be expressed at the
cardiac muscle using bioinformatics, does not necessarily mean that they modulate the heartbeat.
These receptors could act in other ways such as, regulating metabolism or mediating another
system that cannot be physiologically recorded at present. The receptors could also be expressed
conditionally or be non-functional in the cardiac muscle.
Little is known concerning the mechanisms by which other neuromodulators actually
modulate the NMJ or muscle fibers. GYS and SGRN are two peptides that have been studied in
the American lobster; both were found to cause an increase in contraction amplitude at the
periphery, but it is still unknown whether they exert effects at the NMJ and/or the cardiac muscle
(Dickinson et al., 2015). Other neuropeptides that have been found to have enhancing effects on
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the cardiac neuromuscular system by increasing both the amplitude and frequency of the heart
contraction in whole heart preparations, include DH31, sulkakinin, octopamine, and to a lesser
extent tyramine (Christie et al., 2010; Dickinson et al., 2007; unpublished data by Anthony
Yanez). My data show that both DH31 and octopamine are predicted to have receptors located in
the cardiac muscle. In future research, similar methodology to the myosuppressin experiments
described here could be used to discover if GYS and/or SGRN modulate the periphery through
the NMJ, muscle, or both. Additionally, other modulators such as DH31, octopamine, sulkakinin,
and tyramine could be investigated in this way. Using the CPG-effector system to study the
mechanisms of modulation will give us a greater understanding of neuronal circuits at large and
can provide insight into how lesser known circuits operate.
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Chapter 5: Figures and Tables

Figure 1. A ventral view of the cardiac neuromuscular system of the lobster. The Y shape of
the cardiac ganglion is illustrated, with the motor neurons in red and the pacemaker interneurons
in green. The two ovals over the two branches of the “Y” are the ostia where hemolymph enters
the heart. The arteries are located at the posterior and anterior end of the system (Dickinson et
al., 2016).
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Figure 2. A schematic diagram of the CPG-effector system and its closed feedback system.
The nitric oxide response is a negative feedback pathway while a stretch sensitive response is a
positive feedback pathway. Neuromodulators that modulate at the level of the CPG, NMJ, or
effector site can in turn modulate other regions within the CPG-effector system.
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Figure 3. Example of the facilitation of EJPs. A nerve was stimulated with ten identical pulses
at 40Hz, resulting in a facilitation of the EJPs (Crider & Cooper, 2000).
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Figure 4. Myosuppressin increases amplitude and decreases frequency of the muscle
contraction in the whole heart of the American lobster. An example of a whole heart
recording with myosuppressin at 10-6M (application illustrated by the black line). The recording
measures force in grams on the y-axis and time in seconds on the x-axis (Stevens et al. 2009).
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Figure 5. Myosuppressin caused an increase in contraction more than double the
contraction at baseline in the periphery of the cardiac neuromuscular system of the
American lobster. (A) An example recording of the heart’s contractile force at just the
periphery. The periphery was isolated through removing the cardiac ganglion and then the motor
nerve was stimulated thirteen times at 60Hz with 300ms bursts. (B) With a higher speed
recording, there is a visible increase in the contractile force with myosuppressin (black)
compared to baseline (green) from the start stimulation (orange) to the end of the thirteen bursts.
The recording measures force in grams on the y axis and time in seconds on the x axis (Stevens
et al., 2009).
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Figure 6. Comparing endogenous EJPs to stimulated EJPs. (A) Spontaneous excitatory
junction potentials (EJPs) are a result of bursts of action potentials coming from the intact
cardiac ganglion. (B) Recording of excitatory junction potentials (EJPs) at the neuromuscular
junction (NMJ) when the cardiac ganglion was removed, so the neural activity at the NMJ was
isolated. Each EJP results from a single stimulus to the motor nerve—indicated by the black
arrows (note the stimulus artifact before each EJP). Note the differing time scales for A and B.
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Figure 7. Experimental set up for measuring glutamate-evoked contractions from the
cardiac muscle (an experiment model modified from Matthew Maguire’s thesis (2019)). The
muscle end holders have hooks, which held the cardiac muscle bundle in place. The white
patches where the hooks meet the muscle are representative of the GluTru that helped in holding
the muscle in place. The force transducer then placed on the center of the muscle bundle, which
measured the contraction force of the cardiac muscle. The glass microelectrode, represented by
the clear triangle attached to the salmon colored electrode holder, was filled with glutamate and
puffed onto the muscle fiber that was being measured by the force transducer. Note the removed
cardiac ganglion, which would normally reside in between the left and right longitudinal muscle.
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Figure 8. Myosuppressin caused no significant change in EJP amplitude at the
neuromuscular junction in the heart of the American lobster. The mean amplitude of
stimulated (a) EJP 1, (b) EJP 2, and (c) EJP 3 was calculated from the saline control (teal; EJP 1
(5.62 ± 3.69), EJP 2 (5.11 ± 3.42), EJP 3 (5.41 ± 3.45)) and the application of 10-7M
myosuppressin (orange; EJP 1 (5.01 ± 2.54), EJP 2 (4.46 ± 1.91), EJP 3 (4.50 ± 2.06)). There
was no significant difference in the amplitude of EJPs between control and myosuppressin (p>
0.05, paired t-test; N= 6).
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Figure 9. Myosuppressin resulted in an increase in the amplitude of glutamate-evoked
contractions when the endogenous cardiac ganglion activity was eliminated. Both
contractions were stimulated by a glutamate (10-4M) puff, the time of these puffs is indicated by
the blue arrows. The recording measures the force in grams (g) on the y-axis and time in seconds
on the x-axis.

37

*

0.003
0.002
0.001

M

yo

10

on
tr

-7

ol

M

0.000

C

Mean Glu-Evoked Contraction Amplitude (g)

0.004

Figure 10. Myosuppressin increased glutamate-evoked contraction amplitude in the isolated
cardiac muscle. The mean glutamate-evoked contraction amplitude from the isolated cardiac
muscle in control saline (blue; 0.00158 ± 0.00049) and in myosuppressin 10-7M (green; 0.002 ±
0.00050). Contraction amplitude to myosuppressin application in response to glutamate puff
(paired t-test, p< 0.05; N= 5).
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Neuropeptides
ACP
AST-A
AST-B
AST-C
Bursicon A
Bursicon B
CabTRP
CCAP
CCHamide 2
Corazoin
DH31
DH44
EFLamide
Elevenin
FMRFamide
MIH
Myosuppressin
Proctolin
Pyrokinin
Relaxin
RPCH
SIFamide
Sulfakinin
Trissen
Vasopressin

CG
-^
+
+
-*
-*
+
+
+
-*
-

Table 1. Summary of the predictions made about whether the neuropeptide is synthesized
and released in the cardiac ganglion using the H. americanus cardiac ganglion combo
transcriptome. Those neuropeptides that were predicted to be synthesized and released at the
cardiac ganglion are indicated by ‘+,’ while those that were not are indicated by ‘-.’
* - Alignment was inconclusive
^ - Alignment was too small
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Neuropeptide
AST-C
CabTRP
Myosuppressin

Proctolin
RPCH

Trinity Number
TR71619|c0_g1_i1
TR91706|c0_g1_i2
TR91706|c0_g1_i1
TR26925|c0_g1_i3
TR26925|c0_g1_i2
TR26925|c0_g1_i1
TR46909|c0_g1_i2
TR46909|c0_g1_i1
TR68520|c0_g1_i1

Completeness
of transcript
Partial
Partial
Partial
Full
Full
Full
Full
Full
Full

Percent Identity
91.4
100
100
100
100
100
100
100
100

Table 2. Compiled data about the putative neuropeptides predicted to be synthesized and
released in the cardiac ganglion. Predictions were based on the neuropeptide’s sequence
alignment to their query sequence. The trinity number is an identifier for a nucleotide sequence
in the cardiac ganglion combo transcriptome of H. americanus. The trinity numbers that are
grouped by color are identical protein sequences. Percent identity was calculated by the number
of matching amino acids over the number of total amino acids (that overlapped with the putative
peptide sequence).
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Receptor
ACP
AST-A
AST-C
Bursicon
CCAP
CCHamide
Corazoin
DH31
DH44
EFLamide
FMRFamide
Myosuppressin
Proctolin
Pyrokinin
RPCH
SIFamide
Sulfakinin
Tackykinin
Amines
Dopamine
Octopamine
Octopamine β
OctTyr Combo
Serotonin
Tyramine

CM
+
+
-*
+
+
0
+
-*
-

CG
+
+
+
+
-*
+
+
+
+
+
-

0
+
+
-*

0
-*
+
+
-*

Table 3. Summary of the presence of predicted receptors in the cardiac ganglion (CG) and
the cardiac muscle (CM) using the tissue-specific transcriptomes of H. americanus. Those
receptors that were predicted to be located at the cardiac ganglion/muscle are indicated by ‘+,’
while those that were not are indicated by ‘-.’
* - Alignment was inconclusive
0- Not searched for in the transcriptome
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Receptor
ACP

Variant

Receptor 1
Receptor 1
AST-C
Receptor 2
Receptor 2
Receptor 2
Receptor 4
Receptor 4
Receptor 4
Receptor 4
Receptor 4
Bursicon
Receptor 1
Receptor 1
CCAP
Receptor 1
Receptor 1
DH31
Receptor 1
Receptor 1
DH44
Receptor 1
Receptor 1
Receptor 2
Receptor 2
Receptor 2
Myosuppressin
Receptor 2
Receptor 2
Receptor 3
Receptor 4 V1
Receptor 4 V1
Receptor 4 V1
Receptor 4 V2,3
Receptor 4 V2,3
Receptor 4 V2,3
Proctolin
Receptor 1
Receptor 1
Receptor 1
Receptor 1
Receptor 1
Receptor 2
Receptor 2
Receptor 2
Pyrokinin
Receptor 1
Amines
Receptor 2
Octopamine β

Trinity Number

Percent Identity

TR2344|c2_g3_i1
TR2344|c2_g3_i2
TR8916|c1_g2_i4
TR8916|c1_g2_i2
TR8916|c1_g2_i1
TR56862|c4_g5_i1
TR56862|c4_g4_i1
TR56862|c4_g3_i1
TR56862|c4_g2_i1
TR56862|c4_g1_i1
TR45425|c0_g1_i1
TR68968|c0_g1_i1
TR86078|c0_g1_i1
TR3748|c0_g1_i1
TR7828|c0_g1_i1
TR7828|c0_g1_i2
TR7124|c0_g1_i1
TR52110|c0_g1_i1
TR17601|c0_g1_i1
TR50316|c0_g1_i1
TR18146|c0_g1_i1
TR22607|c0_g1_i3
TR22607|c0_g1_i1
TR27825|c0_g1_i1
TR38943|c0_g1_i4
TR38943|c0_g1_i3
TR38943|c0_g1_i1
TR38943|c0_g1_i4
TR38943|c0_g1_i3
TR38943|c0_g1_i1
TR31134|c0_g2_i4
TR31134|c0_g2_i3
TR31134|c0_g2_i2
TR31134|c0_g2_i1
TR31134|c0_g2_i5
TR388|c0_g1_i2
TR388|c0_g1_i3
TR388|c0_g1_i1
TR19456|c0_g1_i1

Completeness
of transcript
Partial
Partial
Full
Full
Full
Full
Full
Full
Full
Full
Partial
Partial
Partial
Partial
Full
Partial
Partial
Partial
Partial
Partial
Partial
Full
Partial
Partial
Full
Full
Full
Partial
Partial
Partial
Full
Full
Full
Full
Partial
Partial
Partial
Partial
Partial

TR29189|c0_g1_i1

Partial

100

100
100
100
100
100
100
100
100
100
100
100
100
100
100
99.6
99.7
100
100
100
100
100
100
100
100
100
100
100
100
100
100
99.8
99.8
99.8
99.8
99.7
100
100
100
100
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Serotonin

Receptor 2
TR7749|c0_g1_i1
Type 7 Receptor TR30021|c1_g2_i2
Type 7 Receptor TR30021|c1_g2_i1

Partial
Full
Full

100
100
100

Table 4. Compiled data about the receptors predicted to be expressed in the cardiac
ganglion, including the variants of the receptors. The trinity number is an identifier for a
nucleotide sequence in the cardiac ganglion combo transcriptome of H. americanus. The trinity
numbers that are grouped by color are identical protein sequences. Percent identity was
calculated by the number of matching amino acids over the number of total amino acids (that
overlapped with the putative receptor sequence).
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Receptor
AST-C
Bursicon
DH31
DH44
Myosuppressin
Amines
Octopamine β
Serotonin

Variant

Trinity Number
TR42870|c0_g1_i1
TR42870|c0_g1_i1
TR22406|c0_g1_i1
TR27789|c0_g1_i1
TR48162|c0_g1_i2
TR48162|c0_g1_i1
TR32466|c0_g1_i1
TR17352|c0_g1_i1
TR17352|c0_g1_i1

Completeness
of transcript
Partial
Partial
Partial
Partial
Partial
Partial
Partial
Partial
Partial

Percent
Identity
83.4
100
100
100
100
99.1
100
100
100

Receptor 1
Receptor 2
Receptor 1
Receptor 1
Receptor 2
Receptor 2
Receptor 1
Receptor 4 Variant 1
Receptor 4 Variant 2
Receptor 2
Receptor 2
Type 7 Receptor
Type 7 Receptor
Type 7 Receptor
Type 7 Receptor

TR42209|c0_g1_i1
TR34866|c0_g1_i1
TR54400|c0_g1_i1
TR40843|c0_g1_i1
TR14406|c0_g1_i2
TR14406|c0_g1_i1

Partial
Partial
Partial
Partial
Partial
Partial

100
100
98.7
100
100
100

Table 5. Compiled data about the receptors predicted to be expressed in the cardiac muscle,
including the variants of the receptors. The trinity number is an identifier for a nucleotide
sequence in the cardiac muscle transcriptome of H. americanus. The trinity numbers that are
grouped by color are identical protein sequences. Percent identity was calculated by the number
of matching amino acids over the number of total amino acids (that overlapped with the putative
receptor sequence).
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